デフォルト表紙
市場調査レポート
商品コード
1672224

先進創傷治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global Advanced Wound Care Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033


出版日
ページ情報
英文 189 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
先進創傷治療の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

先進創傷治療の世界市場規模は2024年の115億9,000万米ドルから2033年には199億8,000万米ドルに成長し、2026~2033年の予測期間中に6.3%の堅調な年間平均成長率(CAGR)を示すと予測されます。

先進創傷治療市場は、慢性創傷の増加や効果的な創傷管理の重要性に対する意識の高まりに後押しされ、パラダイムシフトを経験しています。世界的に高齢化が進み、糖尿病や肥満などの疾患の罹患率が上昇するにつれて、先進創傷治療ソリューションへの需要が高まっています。これらのソリューションは、ハイドロゲル、アルギン酸塩、抗菌ドレッシング材など様々な製品を包含し、治癒を促進し感染リスクを低減することで、患者の転帰を改善するように設計されています。

技術的進歩がこの市場の進化の最前線にあり、創傷治療材料や送達システムの革新が治療効果を高めています。生体工学による代用皮膚や創傷の状態をリアルタイムでモニターするスマートドレッシング材の開発は、従来の創傷管理に革命をもたらしています。このような最先端のソリューションは治癒を早めるだけでなく、医療プロバイダーに重要なデータを提供し、患者のケアに関して十分な情報を得た上で意思決定できるようにします。

さらに、個別化医療への注目が高まるにつれ、個々の患者のニーズに合わせて創傷治療製品をカスタマイズする動きも活発化しています。この動向により、メーカーと医療専門家の連携が促進され、創傷の特徴に対応したテーラーメイドのソリューション開発が進むと予想されます。さらに、遠隔医療や遠隔モニタリング技術の台頭により、先進創傷治療へのアクセスが向上し、頻繁に病院を訪れることなくタイムリーな治療を受けられるようになっています。まとめると、先進創傷治療市場は、技術革新、個別化、患者のQOL向上への取り組みを特徴とし、大幅な成長を遂げようとしています。

当レポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供できるよう、綿密に作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています。

市場概要:市場概要:定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因:市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析:製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢:市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測:過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析:地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会:現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 先進創傷治療産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 先進創傷治療の世界市場分析:製品別

  • 製品別概要
  • 製品別過去・予測データ分析
  • モイストドレッシング(フォームドレッシング、ハイドロコロイドドレッシング、フィルムドレッシング、アルジネートドレッシング、ハイドロゲルドレッシング、コラーゲンドレッシング、その他アドバンストドレッシング)
  • 抗菌(銀、非銀)
  • 活性(生体材料、皮膚代替物、成長因子)

第6章 先進創傷治療の世界市場分析:用途別

  • 用途別概要
  • 用途別過去・予測データ分析
  • 慢性創傷(糖尿病性足潰瘍、褥瘡、静脈性下腿潰瘍、その他の慢性創傷)
  • 急性創傷(手術創・外傷創、熱傷)

第7章 先進創傷治療の世界市場分析:最終用途別

  • エンドユーザー別概要
  • 最終用途別過去・予測データ分析
  • 病院
  • 専門クリニック
  • 在宅医療
  • その他

第8章 先進創傷治療の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州:セグメント別
    • 欧州:国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋:セグメント別
    • アジア太平洋:国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ:セグメント別
    • ラテンアメリカ:国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ:セグメント別
    • 中東・アフリカ:国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 先進創傷治療企業の競合情勢

  • 先進創傷治療市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • MoLnlycke Health Care AB
  • B. Braun Melsungen AG
  • 3M
  • Urgo
  • Coloplast Corp.
  • Integra LifeSciences
  • Medline Industries Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Moist (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Other Advanced Dressings) Market Sales By Geography (USD MN)
  • Antimicrobial (Silver, Non-Silver) Market Sales By Geography (USD MN)
  • Active (Biomaterials, Skin-Substitute, Growth Factors) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Chronic Wounds Market Sales By Geography (USD MN)
  • Acute Wounds (Surgical & Traumatic Wounds, Burns) Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Home Healthcare Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Advanced Wound Care Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Advanced Wound Care Report
  • Market Research Process
  • Market Research Methodology
  • Global Advanced Wound Care Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Moist (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Other Advanced Dressings) Market Sales By Geography (USD MN)
  • Antimicrobial (Silver, Non-Silver) Market Sales By Geography (USD MN)
  • Active (Biomaterials, Skin-Substitute, Growth Factors) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Chronic Wounds Market Sales By Geography (USD MN)
  • Acute Wounds (Surgical & Traumatic Wounds, Burns) Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Home Healthcare Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11210187

Global Advanced Wound Care Market size is anticipated to grow from USD 11.59 Billion in 2024 to USD 19.98 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period of 2026 to 2033.

The advanced wound care market is experiencing a paradigm shift, fueled by an increasing prevalence of chronic wounds and a growing awareness of the importance of effective wound management. As the global population ages and the incidence of conditions such as diabetes and obesity rises, the demand for advanced wound care solutions is escalating. These solutions, which encompass a range of products including hydrogels, alginates, and antimicrobial dressings, are designed to promote healing and reduce the risk of infection, thereby improving patient outcomes.

Technological advancements are at the forefront of this market's evolution, with innovations in wound care materials and delivery systems enhancing the efficacy of treatments. The development of bioengineered skin substitutes and smart dressings that monitor wound conditions in real-time is revolutionizing traditional wound management practices. These cutting-edge solutions not only facilitate faster healing but also empower healthcare providers with critical data to make informed decisions regarding patient care.

Furthermore, the increasing focus on personalized medicine is driving the customization of wound care products to meet the specific needs of individual patients. This trend is expected to foster collaboration between manufacturers and healthcare professionals, leading to the development of tailored solutions that address unique wound characteristics. Additionally, the rise of telemedicine and remote monitoring technologies is enhancing access to advanced wound care, allowing patients to receive timely interventions without the need for frequent hospital visits. In summary, the advanced wound care market is poised for substantial growth, characterized by innovation, personalization, and a commitment to improving patient quality of life.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

  • Moist (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Other Advanced Dressings)
  • Antimicrobial (Silver, Non-Silver)
  • Active (Biomaterials, Skin-Substitute, Growth Factors)

By Application

  • Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Chronic Wounds
  • Acute Wounds (Surgical & Traumatic Wounds, Burns)
  • By-End-Use
  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others
  • COMPANIES PROFILED
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • B. Braun Melsungen AG
  • 3M
  • URGO
  • Coloplast Corp.
  • Integra LifeSciences
  • Medline Industries Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ADVANCED WOUND CARE INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-Use
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ADVANCED WOUND CARE MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Moist (Foam Dressings, Hydrocolloid Dressings, Film Dressings, Alginate Dressings, Hydrogel Dressings, Collagen Dressings, Other Advanced Dressings) Historic and Forecast Sales By Regions
  • 5.4. Antimicrobial (Silver, Non-Silver) Historic and Forecast Sales By Regions
  • 5.5. Active (Biomaterials, Skin-Substitute, Growth Factors) Historic and Forecast Sales By Regions

6. GLOBAL ADVANCED WOUND CARE MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, Other Chronic Wounds Historic and Forecast Sales By Regions
  • 6.4. Acute Wounds (Surgical & Traumatic Wounds, Burns) Historic and Forecast Sales By Regions

7. GLOBAL ADVANCED WOUND CARE MARKET ANALYSIS BY END-USE

  • 7.1. Overview By End-Use
  • 7.2. Historical and Forecast Data Analysis By End-Use
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Specialty Clinics Historic and Forecast Sales By Regions
  • 7.5. Home Healthcare Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL ADVANCED WOUND CARE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ADVANCED WOUND CARE COMPANIES

  • 9.1. Advanced Wound Care Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ADVANCED WOUND CARE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. ConvaTec Group PLC
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Smith & Nephew PLC
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. MöLnlycke Health Care AB
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. B. Braun Melsungen AG
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. 3M
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Urgo
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Coloplast Corp.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Integra LifeSciences
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Medline Industries Inc
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies